Bernice Jimenez
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,972 of the $2,440 with a category attached, or 80.8%. 23 manufacturers reported payments, led by Merz North America, Inc. at 49.4% of the total. Reporting peaked in 2024 at $1,464 and has fallen 83.9% since, to $235 in 2025.
Across 56 payments — averaging $43.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$1K
- AbbVie$150
- Abiomed$139
- AstraZeneca$114
- Otsuka America Pharmaceutical, Inc.$101
- Revance Therapeutics, Inc.$100
- plus $631 from 17 others
What the payments were for
- Travel & lodging$46819%
- Food & beverage$1,97281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 15 | $1,206 |
| AbbVie | 1 | $150 |
| Abiomed | 1 | $139 |
| AstraZeneca | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Revance Therapeutics, Inc. | 1 | $100 |
| Bayer | 3 | $82 |
| Amgen(2 entities) | 3 | $80 |
| Novo Nordisk | 3 | $69 |
| Fresenius USA Marketing, Inc. | 3 | $59 |
| Novartis | 2 | $48 |
| Lilly USA, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Emmaus Medical, Inc. | 2 | $29 |
| Almatica Pharma LLC | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Incyte Corporation | 1 | $20 |
| Travere Therapeutics, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,440 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 27 | $5,763 |
| Nifedipine ErNifedipine | 17 | $209 |
| Carvedilol | 15 | $92 |
| Potassium Chloride | 15 | $64 |
| Prednisone | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.